Usana Health Sciences Inc

Usana Health Sciences Inc

USNA

Get informed when a big investor buys or sells

+ Follow
Market Cap$405.82M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Usana Health Sciences IncUsana Health Sciences Inc46.5-2%0.4-
$61.23

Current Fair Value

174.6% upside

Undervalued by 174.6% based on the discounted cash flow analysis.

Share Statistics

Market cap$405.82 Million
Enterprise Value$257.07 Million
Dividend Yield$- (-)
Earnings per Share$0.58
Beta0.73
Outstanding Shares18,398,000

Return

Return on Equity1.63%ROE
Return on Assets1.20%
Return on Invested Capital8.37%

Valuation & Multiples

P/E Ratio46.47P/E Ratio
PEG-231.53PEG
Price to Sales0.45Price to Sales
Price to Book Ratio0.7Price to Book Ratio
Enterprise Value to Revenue0.28
Enterprise Value to EBIT4.94
Enterprise Value to Net Income28
Total Debt to Enterprise0.05
Debt to Equity0.03Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
May 5, 2026
EPS Estimate
$0.44
Average shareholder expectation
Revenue Estimate
$240.99 M
Average shareholder expectation

Next Earnings Call

Expected Date
July 28, 2026
EPS Estimate
$0.43
Average shareholder expectation
Revenue Estimate
$235.00 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.00000%
Total Calls-
Total Puts-▼ 100.00%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %0.22%▼ 55.93%
Total Invested$857,225▼ 99.52%
Investors Holding3▼ 137.00%

ESG Score

No data

About Usana Health Sciences Inc

CEO: Kevin Guest